1. Convection enhanced delivery of EGFR targeting antibody-drug conjugates Serclutamab talirine and Depatux-M in glioblastoma patient-derived xenografts. (24th August 2022) Authors: Porath, Kendra A; Regan, Michael S; Griffith, Jessica I; Jain, Sonia; Stopka, Sylwia A; Burgenske, Danielle M; Bakken, Katrina K; Carlson, Brett L; Decker, Paul A; Vaubel, Rachael A; Dragojevic, Sonja; Mladek, Ann C; Connors, Margaret A; Hu, Zeng; He, Lihong; Kitange, Gaspar J; Gupta, Shiv K; Fel... Journal: Neuro-oncology advances Issue: Volume 4(2022)Supplement 1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Phase I study of anti-epidermal growth factor receptor antibody-drug conjugate serclutamab talirine: Safety, pharmacokinetics, and antitumor activity in advanced glioblastoma. Issue 1 (21st December 2022) Authors: Carneiro, Benedito A; Papadopoulos, Kyriakos P; Strickler, John H; Lassman, Andrew B; Waqar, Saiama N; Chae, Young Kwang; Patel, Jyoti D; Shacham-Shmueli, Einat; Kelly, Karen; Khasraw, Mustafa; Bestvina, Christine M; Merrell, Ryan; Huang, Kevin; Atluri, Harisha; Ansell, Peter; Li, Rachel; Jin, Ja... Journal: Neuro-oncology advances Issue: Volume 5:Issue 1(2023) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗